Intravenous Immunoglobulin Market Overview
The global Intravenous Immunoglobulin (IVIg) market size has been evaluated as moderately growing market and it is expected that the market will continue to grow similarly in the near future. The demand for new products and therapy is growing continuously. The market for Intravenous Immunoglobulin (IVIg) was around US$ 5910.8 million in 2016 and is expected to grow at a CAGR of 5.9% by 2023.
There are plenty of large and small market players which operate in this market: ABEONA THERAPEUTICS (US), Baxter (US), BDI Pharma (US), Biotest AG.(Germany),, China Biologic Products, Inc. (China), CSL Behring (US), Grifols Inc. (Spain), Kedrion S.p.A (us), Octapharma (Switzerland), Shire (Republic of Ireland), AND others.
Biotest AG. Was found in 1946 and based in Germany. Biotest AG is one of the key players in the market. This company employed about 2,527 people throughout the world and total revenue of the company is US$ 622.7million in 2016. In May 2017, Biotest AG sold their US therapy business to ADMA Biologics, Inc. and received specified current products and a rights related to first order for distribution of upcoming products of ADMA Biologics, Inc. in Europe and selected parts of Asia and middle East.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/3137
Intravenous Immunoglobulin Market Segmentation
Intravenous Immunoglobulin (IVIg) Market size has been segmented on the basis of type which comprise Plaque psoriasis, Scalp psoriasis, Nail psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis, Erythrodermic psoriasis and others. Plaque psoriasis is most common type and about 80% of the cases are plaque psoriasis. On the basis of treatment type it segmented into Topical corticosteroids, Vitamin D analogues (Calcipotriene, Calcitriol), Anthralin, Topical retinoids (Retinol, Tretinoin (retinoic acid / retin-A /Steiva-A), Adapalene (Differin), Tazarotene), Calcineurin inhibitors (tacrolimus (Prograf), pimecrolimus (Elidel)), Salicylic acid, Coal tar, Moisturizers, and Others. Vitamin D analogs such as Calcipotriene and Calcitriol very helpful and helps to slow skin cell growth. Topical retinoids like are Retinol, Tretinoin (retinoic acid / retin-A /Steiva-A), Adapalene (Differin), Tazarotene are vitamin A derivatives that helps to reduce inflammation.
Intravenous Immunoglobulin Market Regional Analysis
Considering the global scenario of the market, North America was holding largest market share in global IVIg market in 2016. While the European market, especially Western Europe is growing and second largest market for Global IVIg. Asia-Pacific will be fastest growing market for IVIg during the forecasted period. Middle East and Africa is expected to grow at steady pace during the forecast period.
Intravenous Immunoglobulin Market Players
- Globus Medical, Inc. (U.S.)
- Depuy Synthes Inc. (Johnson Johnson) (U.S.)
- Smith Nephew plc. (UK)
- NuVasive, Inc. (U.S.)
- Stryker Corporation (U.S.)
- Integra LifeSciences Holdings Corporation (U.S.)
- Zimmer Biomet Holdings, Inc. (U.S.)
- Medtronic, plc (Ireland)
- Wright Medical Group N.V. (Netherlands)
- The Orthopedic Implant Company (U.S.)
- Aesculap Implant Systems (U.S.)
- Conmed Corporation (U.S.)
- BioTek Instruments, Inc. (U.S.)
- Arthrocare Corporation (U.S.)
among others are some key companies in the global intravenous immunoglobulin that are listed by MRFR for market research.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/intravenous-immunoglobulin-market-3137
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
